IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q1 2020 Holdings

Filed 2020-05-15 | 11 holdings | $119.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcutis Biotherapeutics, Inc.(ARQT)COM03969K108$118.6M3,979,29299.6%
Springworks Therapeutics IncCOM85205L107$196.6K7,281,3070.2%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$75.0K4,080,2370.1%
Constellation Pharmaceuticals Inc.(CNST)COM210373106$69.3K2,203,5290.1%
Dynavax Technologies Corp.(DVAX)COM268158201$30.8K8,730,7070.0%
Replimune Group Inc(REPL)COM76029N106$28.3K2,838,9680.0%
Savara Inc(SVRA)COM805111101$23.0K5,128,5930.0%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$16.5K1,648,4850.0%
Marinus Pharmaceuticals IncCOM56854Q101$12.1K5,942,7350.0%
Aptinyx IncCOM03836N103$12.0K5,558,4250.0%
Solid Biosciences IncCOM83422E105$9.3K3,871,1640.0%